Ulipristal acetate: understanding its uses for EC and beyond
January 2025. The findings of a proof-of-concept study investigating use of ulipristal acetate (UPA) as part of an abortion regimen, have been published this week. UPA is the active ingredient in the newer generation of emergency contraception (EC) pills. The publication of this research may open a global debate about the development of new indications for well-established reproductive health products and the importance of preserving access to contraception and abortion.
The American Society for Emergency Contraception and European Consortium for Emergency Contraception came together to prepare a set of tools in order to provide background information about this complex topic. For comments or questions, please email us at ecec[at]eeirh[dot]org and kelly [at] americansocietyforec [dot] org.
English:
- New uses for ulipristal acetate (UPA). Embracing scientific progress and sustaining access to emergency contraception (Global edition, January 2025)
- SUMMARY New uses for ulipristal acetate (Global edition, January 2025)
Spanish:
USA edition:
- Versions of these documents adapted to the United States context are available at https://www.americansocietyforec.org/upa-resources
